Cathay Industrial Biotech Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 1,700

Employees

  • Stock Symbol
  • 688065

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $5.51
  • (As of Friday Closing)

Cathay Industrial Biotech General Information

Description

Cathay Biotech Inc is engaged in research, development, production, and sales of new bio-based materials. The company owns the TERRYL brand, which focuses on bio-based polyamide fibers for textiles, and ECOPENT, which serves the engineering materials market.

Contact Information

Formerly Known As
Shanghai Cathay Biotech R&D Center Co., Ltd.
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Building 11, Lane 396, Lvzhou Ring Road
  • Minhang District
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Biotechnology
Other Industries
Specialty Chemicals
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Building 11, Lane 396, Lvzhou Ring Road
  • Minhang District
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cathay Industrial Biotech Stock Performance

As of 13-Nov-2026, Cathay Industrial Biotech’s stock price is $5.51. Its current market cap is $3.97B with 721M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.51 $5.66 $5.30 - $9.25 $3.97B 721M 4.09M $0.13

Cathay Industrial Biotech Financials Summary

As of 30-Sep-2026, Cathay Industrial Biotech has a trailing 12-month revenue of $521M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,446,910 4,403,534 3,136,660 4,485,271
Revenue 520,539 458,198 412,226 298,828
EBITDA 77,220 107,122 102,551 77,322
Net Income 92,417 77,972 68,144 51,806
Total Assets 3,671,556 3,413,364 2,605,646 2,656,854
Total Debt 132,886 71,891 259,907 250,537
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cathay Industrial Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cathay Industrial Biotech‘s full profile, request access.

Request a free trial

Cathay Industrial Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cathay Biotech Inc is engaged in research, development, production, and sales of new bio-based materials. The company ow
Biotechnology
Shanghai, China
1,700 As of 2026

Emeryville, CA
 

Alameda, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cathay Industrial Biotech Competitors (3)

One of Cathay Industrial Biotech’s 3 competitors is Amyris (Biotechnology), a Private Equity-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
Checkerspot Venture Capital-Backed Alameda, CA
Bota Biosciences Venture Capital-Backed Hangzhou, China
You’re viewing 3 of 3 competitors. Get the full list »

Cathay Industrial Biotech Patents

Cathay Industrial Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026066574-A1 A fiber reinforced composite and preparation method therefor Pending 30-Sep-2024
WO-2026026792-A1 A polyamide composition, a polyamide self-crimpling fiber, and a preparation method thereof Pending 02-Aug-2024
WO-2025251276-A1 Method for extracting and refining long-chain dibasic acid and product Pending 07-Jun-2024
WO-2025097559-A1 Long chain dicarboxylic acid, and method for producing long-chain dicarboxylic acid by means of fermentation Inactive 08-Nov-2023
EP-4807012-A1 Method for producing long-chain dicarboxylic acid and long-chain dicarboxylic acid Pending 08-Nov-2023 C12N1/16
To view Cathay Industrial Biotech’s complete patent history, request access »

Cathay Industrial Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cathay Industrial Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cathay Industrial Biotech‘s full profile, request access.

Request a free trial

Cathay Industrial Biotech Investments (3)

Cathay Industrial Biotech’s most recent deal was a Early Stage VC with MoleculeMind for . The deal was made on 17-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MoleculeMind 17-Jun-2026 Early Stage VC Discovery Tools (Healthcare)
Hefei Hydrogen 09-Apr-2025 Joint Venture Other Materials
MoleculeMind 08-Feb-2023 Early Stage VC Discovery Tools (Healthcare)
To view Cathay Industrial Biotech’s complete investments history, request access »

Cathay Industrial Biotech ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Chemicals

Industry

Rank

Percentile

Specialty Chemicals

Subindustry

Rank

Percentile

To view Cathay Industrial Biotech’s complete esg history, request access »

Cathay Industrial Biotech FAQs

  • When was Cathay Industrial Biotech founded?

    Cathay Industrial Biotech was founded in 2000.

  • Where is Cathay Industrial Biotech headquartered?

    Cathay Industrial Biotech is headquartered in Shanghai, China.

  • What is the size of Cathay Industrial Biotech?

    Cathay Industrial Biotech has 1,700 total employees.

  • What industry is Cathay Industrial Biotech in?

    Cathay Industrial Biotech’s primary industry is Biotechnology.

  • Is Cathay Industrial Biotech a private or public company?

    Cathay Industrial Biotech is a Public company.

  • What is Cathay Industrial Biotech’s stock symbol?

    The ticker symbol for Cathay Industrial Biotech is 688065.

  • What is the current stock price of Cathay Industrial Biotech?

    As of 13-Nov-2026 the stock price of Cathay Industrial Biotech is $5.51.

  • What is the current market cap of Cathay Industrial Biotech?

    The current market capitalization of Cathay Industrial Biotech is $3.97B.

  • What is Cathay Industrial Biotech’s current revenue?

    The trailing twelve month revenue for Cathay Industrial Biotech is $521M.

  • Who are Cathay Industrial Biotech’s competitors?

    Amyris (Biotechnology), Checkerspot, and Bota Biosciences are competitors of Cathay Industrial Biotech.

  • What is Cathay Industrial Biotech’s annual earnings per share (EPS)?

    Cathay Industrial Biotech’s EPS for 12 months was $0.13.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process